@misc{10481/78400, year = {2022}, month = {11}, url = {https://hdl.handle.net/10481/78400}, abstract = {Resistin is a polypeptide implicated in inflammatory processes, and as such could be linked to colorectal carcinogenesis. In case-control studies, higher resistin levels have been found in colorectal cancer (CRC) patients compared to healthy individuals. However, evidence for the association between pre-diagnostic resistin and CRC risk is scarce. We investigated pre-diagnostic resistin concentrations and CRC risk within the European Prospective Investigation into Cancer and Nutrition using a nested case-control study among 1293 incident CRC-diagnosed cases and 1293 incidence density-matched controls. Conditional logistic regression models controlled for matching factors (age, sex, study center, fasting status, and women-related factors in women) and potential confounders (education, dietary and lifestyle factors, body mass index (BMI), BMI-adjusted waist circumference residuals) were used to estimate relative risks (RRs) and 95% confidence intervals (CIs) for CRC. Higher circulating resistin concentrations were not associated with CRC (RR per doubling resistin, 1.11; 95% CI 0.94–1.30; p = 0.22). There were also no associations with CRC subgroups defined by tumor subsite or sex. However, resistin was marginally associated with a higher CRC risk among participants followed-up maximally two years, but not among those followed-up after more than two years. We observed no substantial correlation between baseline circulating resistin concentrations and adiposity measures (BMI, waist circumference), adipokines (adiponectin, leptin), or metabolic and inflammatory biomarkers (C-reactive protein, C-peptide, high-density lipoprotein cholesterol, reactive oxygen metabolites) among controls. In this large-scale prospective cohort, there was little evidence of an association between baseline circulating resistin concentrations and CRC risk in European men and women.}, organization = {World Health Organization}, organization = {Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London}, organization = {Danish Cancer Society}, organization = {Ligue contre le Cancer (France)}, organization = {Institut Gustave Roussy (France)}, organization = {Mutuelle Generale de l'Education Nationale (France)}, organization = {Institut National de la Sante et de la Recherche Medicale (Inserm)}, organization = {Deutsche Krebshilfe}, organization = {Federal Ministry of Education & Research (BMBF)}, organization = {Hellenic Health Foundation (Greece)}, organization = {Fondazione AIRC per la ricerca sul cancro}, organization = {Consiglio Nazionale delle Ricerche (CNR)}, organization = {Netherlands Government Netherlands Government}, organization = {World Cancer Research Fund International (WCRF)}, organization = {Netherlands Government}, organization = {Nordforsk, Nordic Centre of Excellence programme on Food, Nutrition and Health (Norway)}, organization = {Instituto de Salud Carlos III}, organization = {Junta de Andalucia}, organization = {Principality of Asturias}, organization = {Regional Government of Basque Country (Spain)}, organization = {Regional Government of Murcia (Spain)}, organization = {Regional Government of Navarra (Spain)}, organization = {Instituto de Salud Carlos III RD06/0020}, organization = {Swedish Cancer Society}, organization = {Swedish Scientific Council (Sweden)}, organization = {Regional Government of Skane and Vasterbotten (Sweden)}, organization = {UK Research & Innovation (UKRI)}, organization = {Medical Research Council UK (MRC)}, organization = {Cancer Research UK}, organization = {Netherlands Government}, organization = {Deutsches Krebsforschungszentrum (Germany) ERC-2009-AdG 232997}, publisher = {MDPI}, keywords = {Pre-diagnostic resistin}, keywords = {Colorectal cancer}, keywords = {Risk}, keywords = {Prospective}, keywords = {Inflammation}, title = {Pre-Diagnostic Circulating Resistin Concentrations Are Not Associated with Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Study}, doi = {10.3390/cancers14225499}, author = {Pham, Thu Thi and Sánchez Pérez, María José}, }